Publication & Citation Trends
Most Cited Works
Publications
27 total
Preclinical development of a miR-132 inhibitor for heart failure treatment PDF
Cited by 207
OpenAlex
Targeting muscle-enriched long non-coding RNA <i>H19</i> reverses pathological cardiac hypertrophy PDF
Cited by 117
OpenAlex
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction PDF
Cited by 76
OpenAlex
MiRNA-181a is a Novel Regulator of Aldosterone–Mineralocorticoid Receptor-Mediated Cardiac Remodelling PDF
Cited by 45
OpenAlex
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis PDF
Cited by 113
OpenAlex
Inhibition of the Cardiac Fibroblast–Enriched lncRNA <i>Meg3</i> Prevents Cardiac Fibrosis and Diastolic Dysfunction PDF
Cited by 352
OpenAlex
Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression PDF
Cited by 226
OpenAlex
Research Topics
MicroRNA in disease regulation
(7)
Cancer-related molecular mechanisms research
(7)
Cardiac Fibrosis and Remodeling
(5)
RNA Research and Splicing
(4)
Extracellular vesicles in disease
(4)
Frequent Co-Authors
Affiliations
Medizinische Hochschule Hannover
Universitätsmedizin Göttingen
Translational Therapeutics (United States)
German Centre for Cardiovascular Research
AstraZeneca (Sweden)